By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ Market Data in USD, Fundamentals in CNY
$9.21
-$1.19
-11.44%
Last Update: 11 Sept 2025, 20:00
$436.47M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$3.50 - $14.30
52 Week Range

ZYBT Stock Price Chart

Explore Zhengye Biotechnology Holding Limited interactive price chart. Choose custom timeframes to analyze ZYBT price movements and trends.

ZYBT Company Profile

Discover essential business fundamentals and corporate details for Zhengye Biotechnology Holding Limited (ZYBT) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

7 Jan 2025

Employees

278.00

CEO

Songlin Song

Description

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

ZYBT Financial Timeline

Browse a chronological timeline of Zhengye Biotechnology Holding Limited corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

ZYBT Stock Performance

Access detailed ZYBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run